AzTrials
AzTrials

AnalgesiaPhase 4NCT00772187

Intraoperative and Postoperative Analgesia for Laparoscopic Surgery.

A Phase 4 study testing morphine, intrathecal analgesia (morphine) and general anesthesia (fentanyl) in people with Analgesia, run by Rambam Health Care Campus at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Main Hypothesis: laparoscopic surgery is very painful to patient during and after surgery. We would like to compare different analgesic methods. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Analgesia
What is being tested?
morphine, intrathecal analgesia (morphine) and general anesthesia (fentanyl)
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteIsrael
Study dates
Oct 2007to Sep 2009
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Laparoscopic (general) Surgery
  • Age>18
  • ASA<4
  • Morning surgery

Who cannot join

  • Patient refusal
  • contra-indication for treatment

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Rambam Health Care Campus

    Haifa, Israel, 31096

Other trials in Israel

About this study

Main Hypothesis: laparoscopic surgery is very painful to patient during and after surgery. We would like to compare different analgesic methods.

Conditions
Analgesia
Being tested
morphine, intrathecal analgesia (morphine), general anesthesia (fentanyl)
Keywords
Laparoscopic surgery (general surgery).
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • morphineDrug

    Single dose: 0.1-0.5 mg

  • intrathecal analgesia (morphine)Drug

    0.1-0.5 mg of morphine

  • general anesthesia (fentanyl)Drug

    general anesthesia alone

Study groups in NCT00772187
Study groupRoleWhat they receive
1ExperimentalGeneral anesthesia + I.V pca
Receives: Drug: general anesthesia (fentanyl)
2ExperimentalGeneral anesthesia + spinal analgesia + I.V pca
Receives: Drug: morphine; Drug: intrathecal analgesia (morphine)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Good analgesic method with minimal side effect.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2008 (estimated)
  2. Study startOct 2007
  3. Primary completionSep 2009
  4. Study completionSep 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00772187
Sponsor's protocol ID
Rambam2690CTIL
Status last verified
Jul 2010
First submitted
21 May 2008
Last updated
22 Sep 2010
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing morphine, intrathecal analgesia (morphine) and general anesthesia (fentanyl) in people with Analgesia, run by Rambam Health Care Campus at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Good analgesic method with minimal side effect.. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in